M. Spreafico

ORCID: 0000-0003-3378-5513
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hemophilia Treatment and Research
  • Blood Coagulation and Thrombosis Mechanisms
  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • Platelet Disorders and Treatments
  • Pharmacogenetics and Drug Metabolism
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Blood donation and transfusion practices
  • Hemostasis and retained surgical items
  • Eicosanoids and Hypertension Pharmacology
  • Liver Diseases and Immunity
  • Hepatitis Viruses Studies and Epidemiology
  • Blood properties and coagulation
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • HIV/AIDS drug development and treatment
  • Cancer Genomics and Diagnostics
  • Genomic variations and chromosomal abnormalities
  • Health Systems, Economic Evaluations, Quality of Life
  • Glycosylation and Glycoproteins Research
  • Respiratory viral infections research
  • Cancer Cells and Metastasis
  • Protein Tyrosine Phosphatases
  • Cytomegalovirus and herpesvirus research
  • Liver Disease and Transplantation

University of Milan
2003-2023

Alessandro Manzoni Hospital
2009-2022

Aziende Socio Sanitarie Territoriali di Lecco
2021

Ospedale Maggiore
2005-2011

Hospital Universitario de Canarias
2007-2011

Sapienza University of Rome
2011

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2004-2011

Inserm
2011

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
2011

Istituti di Ricovero e Cura a Carattere Scientifico
2008-2010

Sekar Kathiresan Benjamin F. Voight Shaun Purcell Kiran Musunuru Diego Ardissino and 95 more Pier M Mannucci Sonia Anand James C. Engert Nilesh J Samani Heribert Schunkert Jeanette Erdmann Muredach P. Reilly Daniel J. Rader Thomas Morgan John A. Spertus Monika Stoll Domenico Girelli Pascal McKeown Chris C Patterson David S Siscovick Christopher J O'Donnell Roberto Elosúa Leena Peltonen Veikko Salomaa Stephen M Schwartz Olle Melander David Altshuler Pier Angelica Merlini Carlo Berzuini Luisa Bernardinelli Flora Peyvandi Marco Tubaro Patrizia Celli Maurizio Ferrario Raffaela Fetiveau Nicola Marziliano Giorgio Casari Michele Galli Flavio Ribichini Marco Rossi Francesco Bernardi Pietro Zonzin Alberto Piazza Jean Yee Yechiel Friedlander Jaume Marrugat Gavin Lucas Isaac Subirana Joan Sala Rafel Ramos James B Meigs Gordon Williams David M Nathan Calum A. MacRae Aki S Havulinna Göran Berglund Joel N. Hirschhorn Rosanna Asselta Stefano Duga M. Spreafico Mark Daly James Nemesh Joshua M. Korn Steven A. McCarroll Aarti Surti Candace Guiducci Lauren Gianniny Daniel B. Mirel Melissa Parkin Noël P. Burtt Stacey B. Gabriel John R Thompson Peter S. Braund Benjamin J. Wright Anthony J Balmforth Stephen G. Ball Alistair S. Hall Patrick Linsel‐Nitschke Wolfgang Lieb Andreas Ziegler Inke R. König Christian Hengstenberg Marcus Fischer Klaus Stark Anika Grosshennig Michael Preuß H‐Erich Wichmann Stefan Schreiber Willem H. Ouwehand Panos Deloukas Michael Scholz Francois Cambien Mingyao Li Zhen Chen Robert Wilensky William Matthai Atif Qasim Hákon Hákonarson Joe Devaney Mary-Susan Burnett

10.1038/ng.327 article EN Nature Genetics 2009-02-08

Chronic infection with the hepatitis delta virus (HDV) is a risk factor for cirrhosis and hepatocellular carcinoma (HCC), but little known whether outcome of predicted by serum markers HDV B (HBV) infection. The aim study was to investigate these correlations in 193 patients chronic who had been followed up median 9.5 years (4.8-19.3). HDV-RNA first measured qualitative in-house nested RT-PCR quantified real-time PCR. RNA levels only appeared significantly associated HCC (univariate...

10.1371/journal.pone.0092062 article EN cc-by PLoS ONE 2014-03-21

Objective Variant alleles of the CYP2C9 gene encoding cytochrome P450 (CYP) enzyme ( 2C9*2 [Arg144Cys] and 2C9*3 [Ile359Leu]) are known to increase anticoagulant effect warfarin decrease mean daily dose required maintain international normalized ratio (INR) prothrombin time within target therapeutic range. However, little information is available on polymorphisms requirements during most critical step therapy, induction phase. Methods This retrospective study evaluated dosages given 125...

10.1016/j.clpt.2003.09.015 article EN Clinical Pharmacology & Therapeutics 2004-03-01

Abstract: The complete blood counts (CBCs) and the differential leukocyte count are among most requested laboratory tests. These tests frequently performed quickly using highly automated system. modern hematological analyzers easy to use can process several samples in a short period of time (e.g., 120 samples/h). Usually, these used for carrying out cell analysis. However, when instrument flags an important outlier value, morphological study with optical microscopy is carried out....

10.21037/jlpm-23-32 article EN Journal of Laboratory and Precision Medicine 2024-01-01

Background and Aims Increasing evidence that a number of malignancies are characterised by tumour cell heterogeneity has recently been published, but there is still lack data concerning liver cancers. The aim this study was to investigate characterise tumour-propagating (TPC) compartments within human hepatocellular carcinoma (HCC). Methods After long-term culture, we identified three morphologically different populations in single HCC specimen, extensively them means flow cytometry,...

10.1371/journal.pone.0021369 article EN cc-by PLoS ONE 2011-06-23

<h3>Objective</h3> Sialic-acid-binding immunoglobulin-like lectin-7 (Siglec-7) is a natural killer (NK) cell inhibitory receptor associated with NK phenotypic and functional abnormalities in HIV-1 infection. We investigated the significance of NK-expressed serum soluble Siglec-7 relation to ability parameters liver necroinflammation fibrosis chronic HCV <h3>Design</h3> were evaluated 130 166 HCV-infected individuals by flow cytometry ELISA, respectively. degranulation cytokine secretion...

10.1136/gutjnl-2015-310327 article EN Gut 2015-12-16

The aim of this case-control study was to analyse the prevalence gynaecological, obstetrical and other more general bleeding symptoms in 114 women affected by various inherited disorders, who were compared with apparently healthy women. Retrospective information collected means two specific questionnaires, one on gynaecological symptoms, special focus presence menorrhagia as defined a pictorial blood loss assessment chart (PBAC); whose severity graded score (BS). Compared normal women, whole...

10.1111/j.1365-2516.2009.02072.x article EN Haemophilia 2009-08-03

Background: In this study, we aimed to investigate the pathological alterations of LDL-cholesterol, HDL-cholesterol, total cholesterol and triglycerides in COVID-19 patients during acute phase infection, after recovery. Methods: A retrospective study was performed examine serum levels on 55 who were hospitalized our center between February April 2020. The lipid profile hematological parameters analyzed same group before (Group before) clinical management after). laboratory tests results...

10.21037/jlpm-20-98 article EN Journal of Laboratory and Precision Medicine 2021-01-01

Abstract Objectives The aim of the study was to evaluate predictive value cell population data (CPD) parameters in comparison with procalcitonin (PCT) and C-reactive protein (CRP) for an early diagnosis sepsis intensive care unit (ICU). effect renal function on CPD, PCT CRP, septic non-septic patients also investigated. Methods This is a retrospective, observational single-center study, performed collected from consecutively admitted ICU Edoardo Bassini Hospital Milan. Patients were divided...

10.1515/cclm-2024-1202 article EN Clinical Chemistry and Laboratory Medicine (CCLM) 2025-01-24

Anticoagulants of the coumarin type are effective drugs for treatment and prevention thromboembolic diseases. However, they have a narrow therapeutic range show inter- intra-individual variability in dose requirement, largely conditioned by both environmental genetic factors.This prospective study investigated, during initial phase acenocoumarol therapy, effect CYP2C9 variant alleles VKORC1 haplotypes, single combination, 220 Italians.CYP2C9*3 was associated with 25% reduction an increased...

10.2217/14622416.9.9.1237 article EN Pharmacogenomics 2008-09-01

BACKGROUND: Nucleic acid testing (NAT)‐based methods for the detection and quantification of human immunodeficiency virus Type 1 (HIV‐1) RNA are used to increase transfusion safety diagnose manage HIV‐1‐infected patients. We describe a novel HIV‐1 recombinant form associated with lack reactivity or substantial underestimation viral load by commercial NAT assays. STUDY DESIGN AND METHODS: observed repeat blood donor seroconverting anti‐HIV in whom HIV was initially undetectable routine...

10.1111/j.1537-2995.2010.02942.x article EN Transfusion 2010-11-18
Coming Soon ...